in

SUTESGO 50 mg Hard Capsule


SUTESGO 50 mg Hard Capsule containing the lively ingredient sunitinib, respectively; It’s categorized as Antineoplastic and Immunomodulatory Brokers, Antineoplastics, Different Antineoplastic Brokers, protein kinase inhibitors and Sunitinib and is among the many licensed medication within the Medicines and Medical Gadgets Company with the ATC code L01XE04. SUTESGO 50 mg, which you’ll be able to receive from the pharmacy with a traditional prescription, is a product of DEVA HOLDING. Temporary info and prospectus paperwork for SUTESGO 50 mg Hard Capsule (Indications, what’s SUTESGO a drug; what to comply with earlier than beginning the drug, SUTESGO dosage; whether or not its use is appropriate for individuals who are breastfeeding or pregnant; interplay, drawbacks; advantages, storage situations; SUTESGO utilization; SUTESGO SUTESGO, resembling negative effects, undesirable-side results and proposals

The publish SUTESGO 50 mg Hard Capsule first appeared on Pharma Internet.

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.
You May Also Like:  DISINOL 2 g+0.5 g+3.5 g/10 ml Solution

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

How to get a Sinovac vaccine appointment? Sinovac vaccine appointment screen 2021

What is sudden infant death syndrome